Please login to the form below
asthma
This page shows the latest asthma news and features for those working in and with pharma, biotech and healthcare.
Vironix and Oxford University partner to advance chronic kidney disease monitoring
The company has already created AI tools for heart failure, chronic obstructive pulmonary disease, asthma and acute respiratory illness.
Latest news
-
GSK’s RSV vaccine Arexvy granted approval by MHRA for older adults
This is partly due to an age-related decline in immunity. RSV can also exacerbate other conditions, including chronic obstructive pulmonary disease, asthma, and chronic heart failure.
-
Sanofi’s amlitelimab shows promise in phase 2b atopic dermatitis trial
The inflammatory skin disease affects an estimated 16.5 million adults in the US
-
GSK’s RSV vaccine shows long-term efficacy in late-stage older adults study
This is partly due to age-related decline in immunity. RSV can also exacerbate other conditions, including chronic obstructive pulmonary disease, asthma and chronic heart failure.
-
GSK’s RSV vaccine approved by European Commission for older adults
This is partly due to age-related decline in immunity. RSV can also exacerbate other conditions, including chronic obstructive pulmonary disease, asthma and chronic heart failure.
-
Pfizer’s RSV vaccine approved by FDA for older adults
This is partly due to age-related decline in immunity. RSV can also exacerbate other conditions, including chronic obstructive pulmonary disease, asthma and chronic heart failure.
More from news
Approximately 80 fully matching, plus 517 partially matching documents found.
Latest Intelligence
-
Beyond the hype: the future of AI in pharmaceutical marketing
Write a ‘day in the life’ diary for a patient with severe asthma.
-
LifeArc’s challenge to combat bronchiectasis
Bronchiectasis is the third largest chronic respiratory disease after asthma and COPD and it affects over 300, 000 people across the UK and causes an estimated 1, 500 deaths each year.
-
Envisioning a healthier every day, for every woman
As a company working towards this promise, we are active in a range of therapy areas including reproductive health, heart disease, dermatology, allergies and asthma.
-
Looking to the future of patient empowerment
By Max Noble. Patients, or should we say people, with conditions such as asthma, rheumatoid arthritis and lupus have never had as much access to medical information as they do today.
-
Charting patient pathways with precision for better healthcare
In asthma it is down at around 50% and even in oncology the compliance figures are shocking.
More from intelligence
Approximately 3 fully matching, plus 55 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
inflammation test for managing asthma, across key markets such as the United States, China, and Japan, as well as the rest of the world.
-
Takeda UK & Ireland appoints market access director
company's first respiratory biologic for severe asthma.
-
Enterprise Therapeutics appoints CEO
In his new role, Dr Ford will oversee the development of the company's novel muco-regulatory therapies for patients suffering with chronic obstructive pulmonary disease, cystic fibrosis and severe asthma.
-
Former RBS head takes the reins as GSK chair
the past year, and to develop new products in order to offset the decline of its best-selling asthma drug, Advair, as part of his new remit.
-
GSK's Dr Brett Haumann takes up chief medical officer role at Circassia
Most recently these saw him serve as VP and medicines development leader responsible for the late-stage development of once-daily inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD).
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Time to improve healthcare outcomes
From Davina McCall’s Sex, Myths and the Menopause documentary to the latest research pointing to asthma treatments failing female suffers, a momentum has started to better highlight the male skew
-
HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW
There was also a greater number of generic products. Anticoagulant therapies such as apixaban, rivaroxaban and edoxaban topped the spending charts, while respiratory products such as inhalable treatments for asthma and
-
Article
Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma. ... Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma, and some key findings from recent studies
-
Addressing Climate Impact: The Healthcare Paradox
Boehringer Ingelheim recently introduced the first reusable, propellant-free inhaler for patients with asthma and COPD, supporting objectives of carbon and plastic waste reduction.
-
How will the Tories’ historic win shape the NHS?
For example, with long term conditions such as asthma and diabetes, remote monitoring enables better self-management, which in turn, should lead to fewer hospital admissions, less face-to-face contact
More from PMHub
Approximately 3 fully matching, plus 18 partially matching documents found.
Subscribe to our email news alerts
- Medscape Education’s Large Presence at IDWeek 2023
- WHO recommends second malaria vaccine for children
- Sanofi enters agreement with Janssen to develop E. coli vaccine candidate
- NFID and CDC urge US adults to get vaccinated against flu and COVID-19
- Man vs microbe: the fight against antimicrobial resistance
- Dollo's law
No results were found
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
- HOW TO TRANSFORM YOUR HEALTHCARE BRAND MARKETING FROM MULTI-CHANNEL TO OMNICHANNEL
- In a previous blog, we outlined the role of omnichannel in healthcare and the importance of personalised communications with the suggestion of using modular content to support an omnichannel approach....
